M, C., D, B., R, V., & G, S. (2019). New horizons for the treatment of severe, eosinophilic asthma: Benralizumab, a novel precision biologic. Dove Medical Press.
Style de citation Chicago (17e éd.)M, Caminati, Bagnasco D, Vaia R, et Senna G. New Horizons for the Treatment of Severe, Eosinophilic Asthma: Benralizumab, a Novel Precision Biologic. Dove Medical Press, 2019.
Style de citation MLA (8e éd.)M, Caminati, et al. New Horizons for the Treatment of Severe, Eosinophilic Asthma: Benralizumab, a Novel Precision Biologic. Dove Medical Press, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.